2013
DOI: 10.1093/infdis/jit477
|View full text |Cite
|
Sign up to set email alerts
|

Replacement and Positive Evolution of Subtype A and B Respiratory Syncytial Virus G-Protein Genotypes From 1997–2012 in South Africa

Abstract: Positive selection drove both RSV-A and -B genotypes to evolve, resulting in replacement of all genotypes over the 15-year study period in South Africa.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

10
68
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 81 publications
(79 citation statements)
references
References 34 publications
10
68
1
Order By: Relevance
“…Similarly the predominance of group A RSV over group B viruses was reported from Riyadh in earlier investigations [50,56,59]. Other geographical regions have also described the higher incidence of group A RSV [4,63,64,65]. Two samples (5.7%) were positive for both the groups of RSV in the present study.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Similarly the predominance of group A RSV over group B viruses was reported from Riyadh in earlier investigations [50,56,59]. Other geographical regions have also described the higher incidence of group A RSV [4,63,64,65]. Two samples (5.7%) were positive for both the groups of RSV in the present study.…”
Section: Discussionsupporting
confidence: 90%
“…The BA genotype was also reported from Riyadh in a recent investigation [41]. The BA study sequences clustered with the sequences form Germany, Philippines, Spain, Japan, Argentina, Saudi Arabia, India, South Africa and Brazil [2,6,20,26,32,41,64,73]. …”
Section: Discussionsupporting
confidence: 64%
“…23 Second, advances in the care of infants and children outside of the NICUs have also occurred, and much of the care for those with bronchiolitis has been moved from the inpatient to the outpatient setting. 24 It is also possible that the virus itself has changed 25,26 and that changes could have resulted in decreasing morbidity. The use of palivizumab, first licensed in the United States in 1998, is unlikely to account for the significant changes observed in mortality.…”
Section: Discussionmentioning
confidence: 99%
“…Since then, these BA strain viruses have become the prominent circulating B strains (79)(80)(81)(82)(83)(84)(85). More recently, an A strain with a 72-nucleotide duplication in the C-terminal third of its G protein has become a predominant circulating A strain (79-81, 83, 85-87).…”
Section: Discussionmentioning
confidence: 99%